A Project Ensuring Quality and Cooperation in the Chronic Obstructive Pulmonary Disease (COPD) Treatment
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- COPD
- Sponsor
- AstraZeneca
- Enrollment
- 936
- Locations
- 1
- Primary Endpoint
- Control visits at General practitioners
- Status
- Completed
- Last Updated
- 15 years ago
Overview
Brief Summary
The purpose of this study is to ensure the quality of the COPD treatment in primary care by implementing planned follow-up visits, where the disease condition is evaluated and optimised in accordance with the national COPD recommendations. If relevant the general practitioner (GP) will refer patients to COPD rehabilitation conducted by relevant municipality rehabilitation teams. Secondarily the purpose is to improve collaboration and communication between the local hospital pulmonologist, GPs and the municipality rehabilitation team
Investigators
Eligibility Criteria
Inclusion Criteria
- •COPD diagnose, verified by spirometry
- •Having given informed consent
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Control visits at General practitioners
Time Frame: 6-12 months
Lung function measured by spirometry
Time Frame: 6-12 months
Secondary Outcomes
- Dyspnoea on MRC scale(6-12 months)
- Smoking status(6-12 months)
- Rehabilitation completed in the municipality rehabilitation team(6-12 months)